Amedeo Smart

Free Medical Literature Service


 

Amedeo

Liver Diseases

  Free Subscription

Articles published in
Semin Liver Dis
    July 2021
  1. VAZ K, Goodwin T, Kemp W, Roberts S, et al
    Artificial Intelligence in Hepatology: A Narrative Review.
    Semin Liver Dis. 2021 Jul 29. doi: 10.1055/s-0041-1731706.
    >> Share

  2. ZHOU Y, Tao J, Calvisi DF, Chen X, et al
    Role of Lipogenesis Rewiring in Hepatocellular Carcinoma.
    Semin Liver Dis. 2021 Jul 26. doi: 10.1055/s-0041-1731709.
    >> Share

  3. KAHL S, Putzer J, Roden M
    Novel Antidiabetic Strategies and Diabetologists' Views in Nonalcoholic Steatohepatitis.
    Semin Liver Dis. 2021 Jul 21. doi: 10.1055/s-0041-1732354.
    >> Share

    June 2021
  4. JENG WJ, Liaw YF
    Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis.
    Semin Liver Dis. 2021 Jun 28. doi: 10.1055/s-0041-1729973.
    >> Share

  5. HSU YC, Tseng CH, Huang YT, Yang HI, et al
    Application of Risk Scores for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: Current Status and Future Perspective.
    Semin Liver Dis. 2021 Jun 23. doi: 10.1055/s-0041-1730924.
    >> Share

  6. BRESSON-HADNI S, Spahr L, Chappuis F
    Hepatic Alveolar Echinococcosis.
    Semin Liver Dis. 2021 Jun 23. doi: 10.1055/s-0041-1730925.
    >> Share

  7. SU YY, Li CC, Lin YJ, Hsu C, et al
    Adjuvant versus Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: Clinical and Immunologic Perspectives.
    Semin Liver Dis. 2021 Jun 15. doi: 10.1055/s-0041-1730949.
    >> Share

    May 2021
  8. HAEP N, Florentino RM, Squires JE, Bell A, et al
    The Inside-Out of End-Stage Liver Disease: Hepatocytes are the Keystone.
    Semin Liver Dis. 2021 May 15. doi: 10.1055/s-0041-1725023.
    >> Share

  9. USON JUNIOR PLS, Nagalo BM, Ahn DH, Bekaii-Saab T, et al
    Combination Immunotherapy for Hepatocellular Carcinoma: Where Are We Currently?
    Semin Liver Dis. 2021 May 6. doi: 10.1055/s-0040-1722646.
    >> Share

  10. MOECKLI B, Majno P, Orci LA, Peloso A, et al
    Liver Transplantation Selection and Allocation Criteria for Hepatocellular Carcinoma: A European Perspective.
    Semin Liver Dis. 2021 May 6. doi: 10.1055/s-0041-1723032.
    >> Share

  11. SEKIBA K, Otsuka M, Koike K
    Potential of HBx Gene for Hepatocarcinogenesis in Noncirrhotic Liver.
    Semin Liver Dis. 2021 May 6. doi: 10.1055/s-0041-1723033.
    >> Share

    January 2021
  12. YAO FY, Fidelman N, Mehta N
    The Key Role of Staging Definitions for Assessment of Downstaging for Hepatocellular Carcinoma.
    Semin Liver Dis. 2021 Jan 14. doi: 10.1055/s-0040-1716565.
    >> Share

  13. ROEDIGER R, Fleckenstein J
    Intrahepatic Cholestasis of Pregnancy: Natural History and Current Management.
    Semin Liver Dis. 2021;41:103-108.
    >> Share

  14. STOTTS MJ, Wentworth BJ, Northup PG
    Management of Portal Vein Thrombosis in Cirrhosis.
    Semin Liver Dis. 2021;41:79-86.
    >> Share

  15. WILKINSON PD, Duncan AW
    Differential Roles for Diploid and Polyploid Hepatocytes in Acute and Chronic Liver Injury.
    Semin Liver Dis. 2021;41:42-49.
    >> Share

  16. ZHANG Y, Solinas A, Cairo S, Evert M, et al
    Molecular Mechanisms of Hepatoblastoma.
    Semin Liver Dis. 2021;41:28-41.
    >> Share

  17. DHANASEKARAN R
    Deciphering Tumor Heterogeneity in Hepatocellular Carcinoma (HCC)-Multi-Omic and Singulomic Approaches.
    Semin Liver Dis. 2021;41:9-18.
    >> Share

  18. BYRD K, Alqahtani S, Yopp AC, Singal AG, et al
    Role of Multidisciplinary Care in the Management of Hepatocellular Carcinoma.
    Semin Liver Dis. 2021;41:1-8.
    >> Share

    September 2020
  19. HEIMBACH JK
    Evolution of Liver Transplant Selection Criteria and U.S. Allocation Policy for Patients with Hepatocellular Carcinoma.
    Semin Liver Dis. 2020 Sep 17. doi: 10.1055/s-0040-1709492.
    >> Share

  20. ROWE IA
    Histological Endpoints for Nonalcoholic Steatohepatitis Trials: Lights and Shadows.
    Semin Liver Dis. 2020 Sep 9. doi: 10.1055/s-0040-1709491.
    >> Share

    August 2020
  21. LIZARDO-THIEBAUD MJ, Cervantes-Alvarez E, Limon-de la Rosa N, Tejeda-Dominguez F, et al
    Direct or Collateral Liver Damage in SARS-CoV-2-Infected Patients.
    Semin Liver Dis. 2020;40:321-330.
    >> Share

    June 2020
  22. MANDORFER M, Hernandez-Gea V, Garcia-Pagan JC, Reiberger T, et al
    Noninvasive Diagnostics for Portal Hypertension: A Comprehensive Review.
    Semin Liver Dis. 2020 Jun 18. doi: 10.1055/s-0040-1708806.
    >> Share

  23. KNORR J, Wree A, Tacke F, Feldstein AE, et al
    The NLRP3 Inflammasome in Alcoholic and Nonalcoholic Steatohepatitis.
    Semin Liver Dis. 2020 Jun 11. doi: 10.1055/s-0040-1708540.
    >> Share

  24. IBRAHIM SH, Hirsova P, Malhi H, Gores GJ, et al
    Nonalcoholic Steatohepatitis Promoting Kinases.
    Semin Liver Dis. 2020 Jun 11. doi: 10.1055/s-0040-1713115.
    >> Share

  25. FREEBURG SH, Goessling W
    Hepatobiliary Differentiation: Principles from Embryonic Liver Development.
    Semin Liver Dis. 2020 Jun 11. doi: 10.1055/s-0040-1709679.
    >> Share

    May 2020
  26. SUGAHARA G, Ishida Y, Sun J, Tateno C, et al
    Art of Making Artificial Liver: Depicting Human Liver Biology and Diseases in Mice.
    Semin Liver Dis. 2020;40:189-212.
    >> Share

  27. ABERG F, Farkkila M
    Drinking and Obesity: Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Interactions.
    Semin Liver Dis. 2020;40:154-162.
    >> Share

  28. DOLIN CE, Arteel GE
    The Matrisome, Inflammation, and Liver Disease.
    Semin Liver Dis. 2020;40:180-188.
    >> Share

  29. JORDAN RI, Tandon P
    Emerging Role of Palliative Care in Patients with Advanced Liver Disease.
    Semin Liver Dis. 2020;40:163-170.
    >> Share

  30. HILSCHER MB, Shah VH
    Neutrophil Extracellular Traps and Liver Disease.
    Semin Liver Dis. 2020;40:171-179.
    >> Share

    April 2020
  31. MATSUDA M, Seki E
    Hepatic Stellate Cell-Macrophage Crosstalk in Liver Fibrosis and Carcinogenesis.
    Semin Liver Dis. 2020 Apr 2. doi: 10.1055/s-0040-1708876.
    >> Share

    February 2020
  32. KANG N
    Mechanotransduction in Liver Diseases.
    Semin Liver Dis. 2020;40:84-90.
    >> Share

  33. FICKERT P, Rosenkranz AR
    Cholemic Nephropathy Reloaded.
    Semin Liver Dis. 2020;40:91-100.
    >> Share

  34. LLEO A, Leung PSC, Hirschfield GM, Gershwin EM, et al
    The Pathogenesis of Primary Biliary Cholangitis: A Comprehensive Review.
    Semin Liver Dis. 2020;40:34-48.
    >> Share

    December 2019
  35. KOMUTA M, Yeh MM
    A Review on the Update of Combined Hepatocellular Cholangiocarcinoma.
    Semin Liver Dis. 2019 Dec 30. doi: 10.1055/s-0039-3402515.
    >> Share

  36. LIM CJ, Chew V
    Impact of Viral Etiologies on the Development of Novel Immunotherapy for Hepatocellular Carcinoma.
    Semin Liver Dis. 2019 Dec 6. doi: 10.1055/s-0039-3399534.
    >> Share

    September 2019
  37. EL-SHERIF O, Armstrong MJ
    Peculiarities of Cirrhosis due to Nonalcoholic Steatohepatitis (NASH).
    Semin Liver Dis. 2019 Sep 19. doi: 10.1055/s-0039-1697616.
    >> Share

    August 2019
  38. TANDON P, Berzigotti A
    Management of Lifestyle Factors in Individuals with Cirrhosis: A Pragmatic Review.
    Semin Liver Dis. 2019 Aug 30. doi: 10.1055/s-0039-1696639.
    >> Share

    July 2019
  39. BRUSILOVSKAYA K, Konigshofer P, Schwabl P, Reiberger T, et al
    Vascular Targets for the Treatment of Portal Hypertension.
    Semin Liver Dis. 2019 Jul 17. doi: 10.1055/s-0039-1693115.
    >> Share

  40. CAPPELLI A, Modestino F, Mosconi C, De Benedittis C, et al
    Portal Hypertensive Biliopathy in Adult Patients: Findings and Interventional Radiologic Treatment-A Single-Center Experience.
    Semin Liver Dis. 2019 Jul 4. doi: 10.1055/s-0039-1693514.
    >> Share

  41. THOMAS E, Baumert TF
    Hepatitis B Virus-Hepatocyte Interactions and Innate Immune Responses: Experimental Models and Molecular Mechanisms.
    Semin Liver Dis. 2019 Jul 2. doi: 10.1055/s-0039-1685518.
    >> Share

  42. RIMOLA J
    Heterogeneity of Hepatocellular Carcinoma on Imaging.
    Semin Liver Dis. 2019 Jul 2. doi: 10.1055/s-0039-1693512.
    >> Share

    June 2019
  43. AFIFY AY, Ibrahim SA, Aldamsisi MH, Zaghloul MS, et al
    Competing Endogenous RNAs in Hepatocellular Carcinoma-The Pinnacle of Rivalry.
    Semin Liver Dis. 2019 Jun 26. doi: 10.1055/s-0039-1688442.
    >> Share

  44. YANG JD, Liu MC, Kisiel JB
    Circulating Tumor DNA and Hepatocellular Carcinoma.
    Semin Liver Dis. 2019 Jun 21. doi: 10.1055/s-0039-1688503.
    >> Share

  45. FILLIOL A, Schwabe RF
    Contributions of Fibroblasts, Extracellular Matrix, Stiffness, and Mechanosensing to Hepatocarcinogenesis.
    Semin Liver Dis. 2019 Jun 21. doi: 10.1055/s-0039-1685539.
    >> Share

    May 2019
  46. SOOKOIAN S, Pirola CJ
    Genetics of Nonalcoholic Fatty Liver Disease: From Pathogenesis to Therapeutics.
    Semin Liver Dis. 2019;39:124-140.
    >> Share

  47. KIECKHAEFER JE, Maina F, Wells RG, Wangensteen KJ, et al
    Liver Cancer Gene Discovery Using Gene Targeting, Sleeping Beauty, and CRISPR/Cas9.
    Semin Liver Dis. 2019;39:261-274.
    >> Share

  48. TREVISANI F, Garuti F, Neri A
    Alpha-fetoprotein for Diagnosis, Prognosis, and Transplant Selection.
    Semin Liver Dis. 2019;39:163-177.
    >> Share

  49. SHAH RA, Kowdley KV
    Mechanisms and Treatments of Pruritus in Primary Biliary Cholangitis.
    Semin Liver Dis. 2019;39:209-220.
    >> Share

  50. RAMACHANDRAN A, Jaeschke H
    Acetaminophen Hepatotoxicity.
    Semin Liver Dis. 2019;39:221-234.
    >> Share

    April 2019
  51. NAULT JC, Letouze E
    Mutational Processes in Hepatocellular Carcinoma: The Story of Aristolochic Acid.
    Semin Liver Dis. 2019 Apr 30. doi: 10.1055/s-0039-1685516.
    >> Share

  52. FEHILY SR, Papaluca T, Thompson AJ
    Long-Term Impact of Direct-Acting Antiviral Agent Therapy in HCV Cirrhosis: Critical Review.
    Semin Liver Dis. 2019 Apr 30. doi: 10.1055/s-0039-1685538.
    >> Share

  53. PATTEN DA, Shepherd EL, Weston C, Shetty S, et al
    Erratum: Novel Targets in the Immune Microenvironment of the Hepatic Sinusoids for Treating Liver Diseases.
    Semin Liver Dis. 2019 Apr 16. doi: 10.1055/s-0039-1688409.
    >> Share

  54. WEINBERG EM, Palecki J, Reddy KR
    Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis.
    Semin Liver Dis. 2019 Apr 12. doi: 10.1055/s-0039-1679934.
    >> Share

    March 2019
  55. RODRIGUES SG, Cardenas A, Escorsell A, Bosch J, et al
    Balloon Tamponade and Esophageal Stenting for Esophageal Variceal Bleeding in Cirrhosis: A Systematic Review and Meta-analysis.
    Semin Liver Dis. 2019 Mar 25. doi: 10.1055/s-0039-1678726.
    >> Share

  56. PATTEN DA, Shepherd EL, Weston CJ, Shetty S, et al
    Novel Targets in the Immune Microenvironment of the Hepatic Sinusoids for Treating Liver Diseases.
    Semin Liver Dis. 2019 Mar 25. doi: 10.1055/s-0039-1678727.
    >> Share

  57. MAIERS JL, Malhi H
    Endoplasmic Reticulum Stress in Metabolic Liver Diseases and Hepatic Fibrosis.
    Semin Liver Dis. 2019 Mar 25. doi: 10.1055/s-0039-1681032.
    >> Share

  58. KIM G, Kang ES
    Prevention of Hepatocellular Carcinoma by Statins: Clinical Evidence and Plausible Mechanisms.
    Semin Liver Dis. 2019 Mar 25. doi: 10.1055/s-0039-1679956.
    >> Share

  59. FUJIWARA N, Hoshida Y
    Hepatocellular Carcinoma Risk Stratification by Genetic Profiling in Patients with Cirrhosis.
    Semin Liver Dis. 2019 Mar 25. doi: 10.1055/s-0039-1681031.
    >> Share

    February 2019
  60. YOUNES R, Bugianesi E
    NASH in Lean Individuals.
    Semin Liver Dis. 2019;39:86-95.
    >> Share

  61. URBAN SK, Mocan T, Sanger H, Lukacs-Kornek V, et al
    Extracellular Vesicles in Liver Diseases: Diagnostic, Prognostic, and Therapeutic Application.
    Semin Liver Dis. 2019;39:70-77.
    >> Share

  62. KOK B, Abraldes JG
    Child-Pugh Classification: Time to Abandon?
    Semin Liver Dis. 2019;39:96-103.
    >> Share

  63. DITURI F, Mancarella S, Cigliano A, Chieti A, et al
    TGF-beta as Multifaceted Orchestrator in HCC Progression: Signaling, EMT, Immune Microenvironment, and Novel Therapeutic Perspectives.
    Semin Liver Dis. 2019;39:53-69.
    >> Share

  64. XU MJ, Feng M
    Radiation Therapy in HCC: What Data Exist and What Data Do We Need to Incorporate into Guidelines?
    Semin Liver Dis. 2019;39:43-52.
    >> Share

  65. SALATI M, Braconi C
    Noncoding RNA in Cholangiocarcinoma.
    Semin Liver Dis. 2019;39:13-25.
    >> Share

  66. ALVES VAF, Rimola J
    Malignant Vascular Tumors of the Liver in Adults.
    Semin Liver Dis. 2019;39:1-12.
    >> Share

    November 2018
  67. LIN YY, Tan CT, Chen CW, Ou DL, et al
    Immunomodulatory Effects of Current Targeted Therapies on Hepatocellular Carcinoma: Implication for the Future of Immunotherapy.
    Semin Liver Dis. 2018;38:379-388.
    >> Share

  68. LI Z, Weinman SA
    Regulation of Hepatic Inflammation via Macrophage Cell Death.
    Semin Liver Dis. 2018;38:340-350.
    >> Share

  69. HENKEL AS
    Unfolded Protein Response Sensors in Hepatic Lipid Metabolism and Nonalcoholic Fatty Liver Disease.
    Semin Liver Dis. 2018;38:320-332.
    >> Share

  70. KHAMBU B, Yan S, Huda N, Liu G, et al
    Homeostatic Role of Autophagy in Hepatocytes.
    Semin Liver Dis. 2018;38:308-319.
    >> Share

  71. NADEAU BA, Fecher LA, Owens SR, Razumilava N, et al
    Liver Toxicity with Cancer Checkpoint Inhibitor Therapy.
    Semin Liver Dis. 2018;38:366-378.
    >> Share

  72. HASSAN A, Fontana RJ
    Liver Injury Associated with Sporting Activities.
    Semin Liver Dis. 2018;38:357-365.
    >> Share

  73. LIM C, Lahat E, Osseis M, Sotirov D, et al
    Liver Transplantation for Neuroendocrine Tumors: What Have We Learned?
    Semin Liver Dis. 2018;38:351-356.
    >> Share

  74. KEITEL V, Haussinger D
    Role of TGR5 (GPBAR1) in Liver Disease.
    Semin Liver Dis. 2018;38:333-339.
    >> Share

  75. REICHERT MC, Lammert F
    ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.
    Semin Liver Dis. 2018;38:299-307.
    >> Share

    August 2018
  76. DOU L, Ono Y, Chen YF, Thomson AW, et al
    Erratum: Hepatic Dendritic Cells, the Tolerogenic Liver Environment, and Liver Disease.
    Semin Liver Dis. 2018;38:298.
    >> Share

  77. DEUTSCH-LINK S, Fortuna D, Weinberg EM
    A Comprehensive Review of Hepatic Sarcoid.
    Semin Liver Dis. 2018;38:284-297.
    >> Share

  78. LIU PH, Huo TI, Miksad RA
    Hepatocellular Carcinoma with Portal Vein Tumor Involvement: Best Management Strategies.
    Semin Liver Dis. 2018;38:242-251.
    >> Share

  79. PIANO S, Brocca A, Angeli P
    Renal Function in Cirrhosis: A Critical Review of Available Tools.
    Semin Liver Dis. 2018;38:230-241.
    >> Share

  80. SCHEPIS F, Turco L, Bianchini M, Villa E, et al
    Prevention and Management of Bleeding Risk Related to Invasive Procedures in Cirrhosis.
    Semin Liver Dis. 2018;38:215-229.
    >> Share

  81. SHI SH, Zhai ZL, Zheng SS
    Pyogenic Liver Abscess of Biliary Origin: The Existing Problems and Their Strategies.
    Semin Liver Dis. 2018;38:270-283.
    >> Share

  82. ALFERINK LJM, Kiefte-de Jong JC, Darwish Murad S
    Potential Mechanisms Underlying the Role of Coffee in Liver Health.
    Semin Liver Dis. 2018;38:193-214.
    >> Share

    May 2018
  83. DOU L, Ono Y, Chen YF, Thomson AW, et al
    Hepatic Dendritic Cells, the Tolerogenic Liver Environment, and Liver Disease.
    Semin Liver Dis. 2018;38:170-180.
    >> Share

  84. RIMBAS M, Di Maurizio L, Rizzatti G, Gasbarrini A, et al
    Endoscopic Ultrasound for the Hepatologist: A Comprehensive Review.
    Semin Liver Dis. 2018;38:145-159.
    >> Share

  85. YANG L, Wu T, Li J, Li J, et al
    Bacterial Infections in Acute-on-Chronic Liver Failure.
    Semin Liver Dis. 2018;38:121-133.
    >> Share

  86. LESAFFRE E
    Noninferiority Clinical Trials: The Good, the Bad, and the Ugly.
    Semin Liver Dis. 2018;38:97-102.
    >> Share

    February 2018
  87. TREBICKA J
    Does Transjugular Intrahepatic Portosystemic Shunt Stent Differentially Improve Survival in a Subset of Cirrhotic Patients?
    Semin Liver Dis. 2018;38:87-96.
    >> Share

  88. HLADY RA, Robertson KD
    Genetic and Epigenetic Heterogeneity in Normal Liver Homeostasis and Its Implications for Liver Disease and Hepatocellular Cancer.
    Semin Liver Dis. 2018;38:41-50.
    >> Share

  89. ANDRADE RJ, Medina-Caliz I, Gonzalez-Jimenez A, Garcia-Cortes M, et al
    Hepatic Damage by Natural Remedies.
    Semin Liver Dis. 2018;38:21-40.
    >> Share

  90. AJMERA V, Loomba R
    Can Elastography Differentiate Isolated Fatty Liver from Nonalcoholic Steatohepatitis?
    Semin Liver Dis. 2018;38:14-20.
    >> Share

  91. DARA L
    The Receptor Interacting Protein Kinases in the Liver.
    Semin Liver Dis. 2018;38:73-86.
    >> Share

  92. LALAZAR G, Simon SM
    Fibrolamellar Carcinoma: Recent Advances and Unresolved Questions on the Molecular Mechanisms.
    Semin Liver Dis. 2018;38:51-59.
    >> Share

  93. MANN JP, Valenti L, Scorletti E, Byrne CD, et al
    Nonalcoholic Fatty Liver Disease in Children.
    Semin Liver Dis. 2018;38:1-13.
    >> Share

    November 2017
  94. RICH NE, Parikh ND, Singal AG
    Overdiagnosis: An Understudied Issue in Hepatocellular Carcinoma Surveillance.
    Semin Liver Dis. 2017;37:296-304.
    >> Share

    August 2017
  95. KAMBADAKONE A, Baliyan V, Zhu AX
    Functional Imaging and Assessment of Antitumor Activity in Systemic Therapy for Hepatocellular Carcinoma.
    Semin Liver Dis. 2017;37:259-274.
    >> Share

  96. HEIKENWALDER M, Pikarsky E
    Learning the Roles of the Hepatic Adaptive Immune System in Hepatocellular Carcinoma-Nature's Guide for Successful Cancer Immunotherapy.
    Semin Liver Dis. 2017;37:210-218.
    >> Share

    May 2017
  97. LALIOTI V, Tsubota A, Sandoval IV
    Disorders in Hepatic Copper Secretion: Wilson's Disease and Pleomorphic Syndromes.
    Semin Liver Dis. 2017;37:175-188.
    >> Share

    February 2017
  98. PARES A
    Novel Treatment Strategies for Primary Biliary Cholangitis.
    Semin Liver Dis. 2017;37:60-72.
    >> Share

  99. SANTOS-LASO A, Izquierdo-Sanchez L, Lee-Law PY, Perugorria MJ, et al
    New Advances in Polycystic Liver Diseases.
    Semin Liver Dis. 2017;37:45-55.
    >> Share

  100. TRIPODI A
    Hemostasis in Acute and Chronic Liver Disease.
    Semin Liver Dis. 2017;37:28-32.
    >> Share

  101. MORALES-RUIZ M, Santel A, Ribera J, Jimenez W, et al
    The Role of Akt in Chronic Liver Disease and Liver Regeneration.
    Semin Liver Dis. 2017;37:11-16.
    >> Share

  102. CAMPANA L, Iredale JP
    Regression of Liver Fibrosis.
    Semin Liver Dis. 2017;37:1-10.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016